Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density
- 1 April 2002
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 186 (4) , 717-722
- https://doi.org/10.1067/mob.2002.121896
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Mammographic Density in Postmenopausal Women Treated with Tibolone, Estriol or Conventional Hormone Replacement TherapyClinical Drug Investigation, 2000
- Mammographic breast density during hormone replacement therapy: Differences according to treatmentAmerican Journal of Obstetrics and Gynecology, 1999
- Estrone sulfatase versus estrone sulfotransferase in human breast cancer: potential clinical applicationsThe Journal of Steroid Biochemistry and Molecular Biology, 1999
- Effects of Estrogen and Estrogen–Progestin on Mammographic Parenchymal DensityAnnals of Internal Medicine, 1999
- Effects of sex steroids on proliferation in normal mammary tissueAnnals of Medicine, 1998
- The effects of tiboloneGynecological Endocrinology, 1998
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- The effect of tibolone on proliferation, differentiation and apoptosis in normal breast cellsGynecological Endocrinology, 1997
- Breast patterns as an index of risk for developing breast cancerAmerican Journal of Roentgenology, 1976
- Risk for breast cancer development determined by mammographic parenchymal patternCancer, 1976